• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Hepatitis Test Solution Diagnosis Companies

    ID: MRFR/MED/6012-HCR
    110 Pages
    Kinjoll Dey
    October 2025

    Companies involved in hepatitis test solutions and diagnostics focus on developing and providing products for the accurate detection and diagnosis of hepatitis infections. Hepatitis is a viral infection that affects the liver, and various tests are used to identify the presence of hepatitis viruses and assess the extent of liver damage.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Hepatitis Test Solution Diagnosis Market Research Report - Global Forecast till 2032 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Hepatitis Test Solution Diagnosis Market

    Hepatitis Test Solution Diagnosis Key CompaniesLatest Hepatitis Test Solution Diagnosis Companies Update

    July 2023: Quest Diagnostics, Inc. is a diagnostic testing company. DGX has lately updated their material on Hepatitis C and Alzheimer's disease tests. The company conducted a paper created by CDC specialists utilizing data from the Quest Diagnostics Health Trends research program to support public health policy for Hepatitis, COVID-19, HIV, and other disorders. The most recent launch will broaden Quest Diagnostics' array of testing services, strengthening the Diagnostic Solutions division. DGX is committed to developing cutting-edge laboratory tests to aid in the assessment of patient risk for dementia and other degenerative illnesses. Through its unique AD-Detect set of blood tests, it is providing patients and clinicians with nationwide access to high-quality laboratory innovation for Alzheimer's disease for the first time.


    July 2023: The Elecsys HCV Duo is India's first commercially available fully automated immunoassay that allows simultaneous and independent determination of hepatitis C virus (HCV) antigen and antibody status from a single human plasma or serum sample. This indicates that the test may be used to detect infection in its early stages, as well as when the patient is recuperating from the virus or even during chronic illness. In India, viral hepatitis is gradually being acknowledged as a public health issue. There are around 12-13 million HCV carriers, and modeling results indicate that the disease burden will soon grow significantly. The paradox is that only 19% of persons living with chronic HCV infection are aware of their diagnosis, and only 30% of those diagnosed begin therapy. Those who have the sickness at an early stage are ignorant of their medical condition. As a result, there is a significant gap between diagnosis and therapy.


    List of Hepatitis Test Solution Diagnosis Key companies in the market

    • Abbott

    • Biomérieux Sa

    • Bio-Rad Laboratories, Inc.

    • Danaher

    • DiaSorin S.p.A.

    • Miraca Holdings Inc. (Fujirebio, Inc.)

    • Grifols

    • Onsite Lab Holding AG (MedMira, Inc.)

    • Qiagen

    • Roche Holding AG (Roche Diagnostics)

    • Siemens (Siemens Healthineers)

    • Sandoz International GmbH.